Early Access Program for ALXN1840 in Patients With Wilson Disease

Study Identifier:
D9430R00001
ClinicalTrials.gov Identifier:
NCT05686564
EudraCT Identifier:
N/A
EU CT ID:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Drug: ALXN1840
Date
N/A - N/A
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 3+ years
Requirements Information
Sex
Female & Male
Age
3+ years

Study Details

Medical Condition
  • Unmapped
Study Drug
  • Drug: ALXN1840
Date
N/A - N/A
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 3+ years years
Requirements Information

Protocol Summary

This is an open-label, single-arm, multi-center EAP, designed to provide early access to ALXN1840 for eligible patients with WD.

Trial Locations

No locations found.